U.S. Markets open in 1 hr 39 mins

Analyzing Johnson & Johnson’s Segment-Wise Performance in 1Q18

Mike Benson
Analyzing Johnson & Johnson’s Segment-Wise Performance in 1Q18

Johnson & Johnson (JNJ) reported 8.4% growth in operating revenues and a 4.2% positive impact of foreign exchange to $20.0 billion in 1Q18 as compared to revenues of $17.8 billion during 1Q17. Johnson & Johnson reported growth across all three of its segments: the pharmaceutical segment, the consumer health segment, and the medical devices segment.